Author Correction: Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study (Nature Medicine, (2026), 32, 1, (197-223), 10.1038/s41591-025-04077-9)

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-025-04077-9, published online 6 January. In the version of the article initially published, there was an error in the last sentence of the abstract, where in the text now reading “During the pandemic, the incidence of chronic respiratory diseases increased modestly, but the decline in mortality rates became less pronounced,” “became less pronounced” appeared as “became more pronounced.” In the Results “Disease burden before and during the COVID-19 pandemic” section, a similar error appeared, and some average annual percentage change values were mistakenly interchanged. In the updated text that follows, the original incorrect text or values are shown in brackets. “In contrast, the AAPC of age-standardized death rates of chronic respiratory diseases showed a less [more] pronounced decreasing trend during the pandemic (AAPC, –1.23 [−3.04]) compared with before the pandemic (AAPC, –3.04 [−1.23]; Extended Data Fig. 9). This pattern in mortality trends was also observed for COPD, for which the AAPC in deaths changed from –3.27 to –1.34 [−1.34 to −3.27]. Similarly, asthma showed a shift in death rates from –1.92 to –1.26 [–1.26 to –1.92], whereas asthma … the pandemic). Pneumoconiosis showed a reversing trend in mortality from a decline before the pandemic (AAPC, 0.21 [−1.26]) to a minimal increase (AAPC, –1.26 [0.21]) during the pandemic…. For ILD and pulmonary sarcoidosis, mortality trends reversed from a modest increase (AAPC, –1.99 [1.05]) to a slight decline (AAPC, 1.05 [−1.99]; Fig. 4).” The text is now amended in the HTML and PDF versions of the article.